Results 171 to 180 of about 908,246 (301)

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti   +7 more
wiley   +1 more source

Assessment of genetically modified soybean GMB151 × DAS‐44406‐6 (application GMFF‐2024‐21774, EFSA‐Q‐2024‐00330)

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract Genetically modified soybean GMB151 × DAS‐44406‐6 was developed by crossing to combine two single events: GMB151 and DAS‐44406‐6. The two‐event stack soybean expresses the Cry14Ab‐1, HPPD‐4, PAT, AAD‐12 and 2mEPSPS proteins to confer herbicide tolerance and resistance to plant parasitic nematodes.
EFSA Panel on Genetically Modified Organisms (GMO)   +28 more
wiley   +1 more source

Tuberculosis and leprosy co-infection: Points to remember. [PDF]

open access: yesLung India
Gupta P, Pandey A, Deepak D, Suri A.
europepmc   +1 more source

The Blood Picture of Pyridoxine Deficiency in the Monkey [PDF]

open access: bronze, 1952
KENNETH J. POPPEN   +2 more
openalex   +1 more source

Seizures due to pyridoxine deficiency in Parkinson's disease [PDF]

open access: bronze
Yashwanth Pulluru   +5 more
openalex   +1 more source

Pyridoxine deficiency: new approaches in immunosuppression and chemotherapy.

open access: yesPostgraduate medical journal, 1997
Antonios Trakatellis   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy